Nasdaq

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

Data Also Underscores Potential Benefits of CyberKnife System Sub-millimeter Accuracy in Preserving Quality of Life after Treatment for Prostate Cancer "An extensive number of peer-reviewed scientific ...
The Victoria Advocate

Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025

" Early results from a trial on stereotactic salvage radiotherapy for macroscopic prostate bed recurrence after prostatectomy: STARR (NCT05455736) " is a prospective study evaluating the use of ...
The Washington Post

Experts Debate CyberKnife for Prostate Cancer

When Georgetown University Hospital bought a new high-tech system in 2001 to treat patients with radiation, doctors at first used the computerized, robotic device only for brain and spinal tumors that ...
Houston Chronicle

Accuray's (ARAY) CyberKnife Favored For Prostate Cancer Treatment

Accuray Incorporated ARAY recently announced that its CyberKnife robotic radiotherapy platform has been indicated to be superior to conventional linear accelerators by latest data from the Prostate ...
Seeking Alpha

Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025

MADISON, Wis., May 7, 2025 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting reinforces the ...
WOOD-TV

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

Data Also Underscores Potential Benefits of CyberKnife System Sub-millimeter Accuracy in Preserving Quality of Life after Treatment for Prostate Cancer MADISON, Wis., March 26, 2024 /PRNewswire/ -- ...